KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Accounts Payables: 2009-2024

Historic Accounts Payables for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $589.0 million.

  • Bausch Health Companies' Accounts Payables fell 7.65% to $616.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $616.0 million, marking a year-over-year decrease of 7.65%. This contributed to the annual value of $589.0 million for FY2024, which is 18.08% down from last year.
  • Per Bausch Health Companies' latest filing, its Accounts Payables stood at $589.0 million for FY2024, which was down 18.08% from $719.0 million recorded in FY2023.
  • Bausch Health Companies' 5-year Accounts Payables high stood at $719.0 million for FY2023, and its period low was $337.0 million during FY2020.
  • Its 3-year average for Accounts Payables is $609.7 million, with a median of $589.0 million in 2024.
  • In the last 5 years, Bausch Health Companies' Accounts Payables plummeted by 33.00% in 2020 and then skyrocketed by 38.00% in 2023.
  • Over the past 5 years, Bausch Health Companies' Accounts Payables (Yearly) stood at $337.0 million in 2020, then climbed by 20.77% to $407.0 million in 2021, then grew by 28.01% to $521.0 million in 2022, then soared by 38.00% to $719.0 million in 2023, then dropped by 18.08% to $589.0 million in 2024.